Impact Factor Journals

KOUDELÁKOVÁ, V., J. BERKOVCOVÁ, R. TROJANEC, J. VRBKOVÁ, L. RADOVÁ, J. EHRMANN, Z. KOLÁŘ, B. MELICHAR, M. HAJDÚCH
Evaluation of HER2 Gene Status in Breast Cancer Samples with Indeterminate Fluorescence in Situ Hybridization by Quantitative Real-Time PCR Method. Journal of Molecular Diagnostic. 2015, 17(4), 446-455, ISSN: 1525-1578, PMID: 25956448,  PDF.
BORKOVÁ, L., L. JASILKOVA, J. ŘEHULKA, K. FRISONSOVA, M. URBAN, I. FRYDRYCH, I. POPA, M. HAJDÚCH, N. DICKINSON, M. VLK, P. DŽUBÁK, J. ŠAREK
Synthesis of cytotoxic 2,2-difluoroderivatives of dihydrobetulinic acid and allobetulin and study of their impact on cancer cells. European Journal of Medicinal Chemistry. 2015, 96(-), 482-490, ISSN: 0223-5234, PMID: 25942059,
ZHAI, C., D. SUMMER, C. RANGGER, G. FRANSSEN, P. LAVERMAN, H. HAAS, M. PETŘÍK, R. HAUBNER, C. DECRISTOFORO
Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates. Molecular Pharmaceutics. 2015, 12(6), 2142-2150, ISSN: 1543-8384, PMID: 25941834,
ŘEZNÍČKOVÁ, E., A. POPA, T. GUCKÝ, M. ZATLOUKAL, L. HAVLICEK, V. BAZGIER, K. BERKA, R. JORDA, I. POPA, A. NASEREDDIN, C. JAFFE, V. KRYŠTOF, M. STRNAD
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro. Bioorganic and Medicinal Chemistry Letters. 2015, 25(11), 2298-2301, ISSN: 0960-894X, PMID: 25937014,
HEZOVA, R., A. KOVARIKOVA, J. SROVNAL, M. ZEMANOVÁ, T. HARUSTIAK, J. EHRMANN, M. HAJDÚCH, M. SVOBODA, M. SACHLOVA, O. SLABÝ
Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus. Diagnostic Pathology. 2015, 10(-), Article Number: 42, ISSN: 1746-1596, PMID: 25928282,
KAPLANEK, R., M. JAKUBEK, J. RAK, Z. KEJIK, M. HAVLIK, B. DOLENSKY, I. FRYDRYCH, M. HAJDÚCH, M. KOLÁŘ, K. BOGDANOVÁ, J. KRALOVA, P. DŽUBÁK, V. KRAL
Caffeine-hydrazones as anticancer agents with pronounced selectivity toward T-lymphoblastic leukaemia cells. Bioorganic Chemistry. 2015, 60(-), 19-29, ISSN: 0045-2068, PMID: 25912310,
DAS, V., F. BRUZZESE, P. KONEČNÝ, F. IANNELLI, A. BUDILLON, M. HAJDÚCH
Pathophysiologically relevant in vitro tumor models for drug screening. Drug Discovery Today. 2015, 20(7), 848-55, ISSN: 1359-6446, PMID: 25908576,
DAS, V., F. BRUZZESE, P. KONEČNÝ, F. IANNELLI, A. BUDILLON, M. HAJDÚCH
Pathophysiologically relevant in vitro tumor models for screening of anticancer compounds. Drug Discovery Today. 2015, 20(7), 848-55, ISSN: 1359-6446, PMID: 25908576.
MALNUIT, V., L. SLAVĚTÍNSKÁ, P. NAUŠ, P. DŽUBÁK, M. HAJDÚCH, J. STOLAŘÍKOVÁ, J. SNÁŠEL, I. PICHOVÁ, M. HOCEK
2-Substituted 6-(Het)aryl-7-deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity. ChemMedChem. 2015, 10(6), 1079-1093, ISSN: 1860-7179, PMID: 25882678,
NAJDEKR, L., A. GARDLO, L. MÁDROVÁ, D. FRIEDECKÝ, H. JANEČKOVÁ, E. CORREA, R. GOODACRE, T. ADAM
Oxidized phosphatidylcholines suggest oxidative stress in patients with medium-chain acyl-CoA dehydrogenase deficiency. Talanta. 2015, 139(2015), 62-66, ISSN: 0039-9140, PMID: 25882409,